Showing 1,801 - 1,820 results of 2,687 for search '"chemotherapy"', query time: 0.08s Refine Results
  1. 1801

    An Unusual Presentation of Tumor Lysis Syndrome in a Patient with Advanced Gastric Adenocarcinoma: Case Report and Literature Review by Danica Maria Vodopivec, Jose Enrique Rubio, Alessia Fornoni, Oliver Lenz

    Published 2012-01-01
    “…However, TLS rarely occurs with solid tumors, and here we present the second chemotherapy-induced TLS in a patient with advanced gastric adenocarcinoma to be reported in the literature. …”
    Get full text
    Article
  2. 1802

    3 years survival of patients with multiple myeloma. by Julio Dámaso Fernández Águila, Alexander García Blay, Luis Alberto Corona Martínez, Maritza Cabrera Zamora, Leovaldo Prieto Jiménez., Tamara Guerra Alfonso

    Published 2006-12-01
    “…The 47,1% of the treated patients had a positive response to the chemotherapy. There were no alarming differences in response percentage and in survival among those who received Melfalan-prednisona and those who were treated with schemes that combined both drugs. …”
    Get full text
    Article
  3. 1803

    Conservative Treatment of Uterine Cervical Adenocarcinoma in Pregnancy by Cid Almeida de Lima, Ana Cristina Macêdo Barcelos, Marina de Carvalho Paschoini, João Henrique do Amaral e Silva, Marcus Aurelho de Lima, Eddie Fernando Candido Murta, Rosekeila Simões Nomelini

    Published 2013-01-01
    “…We describe in this report the case of a pregnant woman with invasive cervical adenocarcinoma in stage IB1 (FIGO) initially treated with neoadjuvant chemotherapy, followed by radical surgery and cesarean section in the same surgical procedure.…”
    Get full text
    Article
  4. 1804

    Clinical applications and research progress of totally implantable venous access ports: a literature review by Xiao-Min Huang, Xia Li, Jie Deng, Jiong Chen, Liang Qian

    Published 2025-01-01
    “…Totally implantable venous access port (TIVAP), a novel intravenous infusion system that is used for long-term intravenous treatment, has become increasingly popular among cancer patients undergoing chemotherapy and other patients requiring long-term intravenous infusions. …”
    Get full text
    Article
  5. 1805

    Genetic and epigenetic characterization of sarcoma stem cells across subtypes identifies EZH2 as a therapeutic target by Edmond O’Donnell, Maria Muñoz, Ryan Davis, Jessica Bergonio, R. Lor Randall, Clifford Tepper, Janai Carr-Ascher

    Published 2025-01-01
    “…Failure to respond anthracycline chemotherapy, standard first-line treatment, is associated with poor outcomes. …”
    Get full text
    Article
  6. 1806

    Combination Effects of Docetaxel and Doxorubicin in Hormone-Refractory Prostate Cancer Cells by Eleftheria Tsakalozou, Allison M. Eckman, Younsoo Bae

    Published 2012-01-01
    “…The proposed DOC/DOX mixing ratios can be used to design combination drug cocktails or delivery systems to improve chemotherapy for cancer patients.…”
    Get full text
    Article
  7. 1807

    Quality of Life in Painful Peripheral Neuropathies: A Systematic Review by Ayesha Girach, Thomas Henry Julian, Giustino Varrassi, Antonella Paladini, Athina Vadalouka, Panagiotis Zis

    Published 2019-01-01
    “…Other aetiologies of painful PN where QoL has been studied to date include gluten, immune-mediated, HIV, chemotherapy-induced, and chronic idiopathic axonal polyneuropathy. …”
    Get full text
    Article
  8. 1808

    Epithelioid Angiosarcoma Arising from a Huge Leiomyoma: A Case Report and a Literature Review by Takeya Hara, Ai Miyoshi, Yuji Kamei, Nao Wakui, Akiko Fujishiro, Serika Kanao, Hirokazu Naoi, Hirofumi Otsuka, Takeshi Yokoi

    Published 2018-01-01
    “…She received 6 courses of adjuvant chemotherapy with paclitaxel, epirubicin, and carboplatin, and there have been no signs of recurrence for 10 months.…”
    Get full text
    Article
  9. 1809

    Immunotherapeutic Approaches in Triple-Negative Breast Cancer: State of the Art and Future Perspectives by Karima Oualla, Loay Kassem, Lamiae Nouiakh, Lamiae Amaadour, Zineb Benbrahim, Samia Arifi, Nawfel Mellas

    Published 2020-01-01
    “…It accounts for 15%–20% of all breast cancers and is associated with an aggressive evolution and poor outcomes with the majority of recurrences and deaths occurring in the first 5 years. Chemotherapy remains the mainstay of treatment in the absence of effective targets, but the good understanding of immune tumor microenvironment, the identification of immune-related targets, and the role of tumor-infiltrating lymphocytes (TILs) in TNBC has allowed to develop promising immunotherapeutic strategies for this unique subset of breast cancer. …”
    Get full text
    Article
  10. 1810

    Triplet Therapy with PD-1 Blockade, Histone Deacetylase Inhibitor, and DNA Methyltransferase Inhibitor Achieves Radiological Response in Refractory Double-Expressor Diffuse Large B... by Runhui Zheng, Xiaobo Chen, Chunyan Wang, Pengfei Qin, Huo Tan, Xiaodan Luo

    Published 2020-01-01
    “…The patient failed to respond to the 1st line (R-EPOCH: rituximab, etoposide, vincristine, cyclophosphamide, doxorubicin, and dexamethasone), 2nd line (R-EPOCH + lenalidomide + ibrutinib), and a 3rd line chemotherapy combined with PD-1 inhibitor (sintilimab), decitabine, and GDP (gemcitabine, DDP, and dexamethasone). …”
    Get full text
    Article
  11. 1811

    Epidemiological characteristics of imported malaria related to international travel in the Republic of Korea from 2009 to 2018 by Byoung Hak Jeon, Jung Ah Lee, Shin Young Lee, Sang Eun Lee, Joon Sup Yeom

    Published 2025-01-01
    “…Notably, 71.5% of the patients did not receive prophylactic chemotherapy, and 18% of those who did still developed malaria. …”
    Get full text
    Article
  12. 1812
  13. 1813

    Alveolar Soft Part Sarcoma of Urinary Bladder Occurring as a Second Primary Malignancy: A Case Report and Literature Review by Manint Usawachintachit, Piyada Sitthideatphaiboon, Voranuch Thanakit, Sulada Pukiat, Kamol Panumatrassamee, Julin Opanuraks, Apirak Santi-Ngamkun

    Published 2016-01-01
    “…We report a case of bladder alveolar soft part sarcoma in an 18-year-old Thai male patient who had been treated with testicular radiation and systemic chemotherapy for acute lymphoblastic leukemia with testicular relapse. …”
    Get full text
    Article
  14. 1814

    An Acute Transverse Myelitis Attack after Total Body Irradiation: A Rare Case by Muzaffer Keklik, Leylagul Kaynar, Afra Yildirim, Serdar Sivgin, Celalettin Eroglu, Serife Cingoz, Cigdem Pala, Bulent Eser, Mustafa Cetin, Ali Unal

    Published 2013-01-01
    “…Total body irradiation (TBI) combined with chemotherapy is widely used as a pretreatment regimen of bone marrow transplantation (BMT) in hematologic disorders. …”
    Get full text
    Article
  15. 1815

    Symptomatic Hypoglycemia Related to Inappropriately High IGF-II Serum Levels in a Patient with Desmoplastic Small Round Cell Tumor by Williams Fernandes Barra, Gilberto Castro, Ana Oliveira Hoff, Sheila A. C. Siqueira, Paulo M. Hoff

    Published 2010-01-01
    “…Disease progression was observed despite systemic chemotherapy. Six months after diagnosis, he developed severe hypoglycemia presented with seizures. …”
    Get full text
    Article
  16. 1816

    Langerhans Cell Histiocytosis: A Diagnostic Challenge in the Oral Cavity by Mehmet Ali Altay, Alper Sindel, Öznur Özalp, Burak Kocabalkan, İrem Hicran Özbudak, Ramazan Erdem, Ozan Salim, Dale A. Baur

    Published 2017-01-01
    “…The patient underwent systemic chemotherapy with vinca alkaloids and corticosteroids. …”
    Get full text
    Article
  17. 1817

    Long-Term Survivorship of Esophageal Cancer Patients Treated with Radical Intent by Alex Agranovich, Colleen E McGahan, Anagha Gurjal

    Published 2008-01-01
    “…Seventy-seven patients were treated with radiation therapy (RT) only and 61 with combined regimens (CRT), in which RT was combined with either radical surgery or chemotherapy, or both. The overall survival of the entire cohort was 32% over two years and 20% over five years. …”
    Get full text
    Article
  18. 1818

    Biomarker panel for early detection of uterine cancer by Nemali Deepthi Deepthi Priya, NANDA KUMAR K V, DEVARAJAPPAGARI BINDU, KASIREDDY LIKHITHA, MEKALA SIVA CHARANI

    Published 2024-10-01
    “…Various treatments modalities, including surgery, Chemotherapy, targeted therapies are examined. In conclusion, early detection through biomarkers like P53, K-RAS, HER2/neu, PTEN, Serum CA-125 holds great promise for early diagnosis and treatment advancements, and offering hope for improved outcomes and a better quality of life for patients in the future. …”
    Get full text
    Article
  19. 1819

    Peiminine Enhances Doxorubicin Cytotoxicity and Downregulates hsa-miR-106a-5p and hsa -miR-181a-5p in Human Gastric Adenocarcinoma Cells by Shirin Hedayati, Hossein Soltanzadeh, Hadi Esmaeili Gouvarchin Ghaleh, Zahra Hojjati Bonab, Akbar Ghorbani Alvanegh

    Published 2024-12-01
    “…Background: Gastric cancer (GC) is a prevalent and deadly cancer worldwide. Chemotherapy is the primary treatment, but some patients use herbal remedies, such as Peiminine from Fritillaria walujewii, for palliative care. …”
    Get full text
    Article
  20. 1820

    Targeting epithelial-mesenchymal transition signaling pathways with Dietary Phytocompounds and repurposed drug combinations for overcoming drug resistance in various cancers by A.N.K.V. Sravani, John Thomas

    Published 2025-02-01
    “…It enhances the ability of cancer cells' to self-renew and initiate tumors, while also increasing resistance to apoptosis and chemotherapy. Among the signaling pathways a few signaling pathways such as Notch, TGF-beta, and Wnt-beta catenin are critically involved in the epithelial-to-mesenchymal transition (EMT) acquisition. …”
    Get full text
    Article